Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel recommends unblinding study after Imbruvica shows clear benefit
FDA panel recommends unblinding study after Imbruvica shows clear benefit
FDA panel recommends unblinding study after Imbruvica shows clear benefit
Submitted by
admin
on March 17, 2015 - 8:17am
Source:
Yahoo/Reuters
News Tags:
FDA
advisory panels
Imbruvica
Pharmacyclics
JNJ
AbbVie
Headline:
FDA panel recommends unblinding study after Imbruvica shows clear benefit
Do Not Allow Advertisers to Use My Personal information
